Streetbeat News

Regulatory

AMLX

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a negative opinion on Amylyx Pharmaceuticals' conditional marketing authorization of AMX0035 for amyotrophic lateral sclerosis (ALS). This contradicts positive approvals from the FDA and Health Canada. Amylyx plans to request a formal re-examination of the Marketing Authorization Application procedure.

Portfolio Pulse from Vandana Singh

June 23, 2023 | 1:27 pm

HMC

Honda Motor Company (NYSE:HMC) is recalling 1.2 million vehicles in the US due to a defective communication coaxial cable connector affecting the rearview camera display. The recall covers some 2018-2023 Odyssey, 2019-2022 Pilot, and 2019-2023 Passport vehicles. HMC shares traded lower by 2.94% at $30.05 premarket on Friday.

Portfolio Pulse from Anusuya Lahiri

June 23, 2023 | 1:24 pm

AMZN

BA

BTCUSD

JPM

MMM

NKLA

A crypto analyst predicts Bitcoin could break $32K due to BlackRock's ETF filing. Nikola continues test road trips despite weak demand and internal conflict. Retailers' subscriptions, including Amazon Prime and Walmart+, face FTC scrutiny. 3M settles a PFAS-related lawsuit for $10.3B. Boeing invests $100M in pilot training in India. JPMorgan pays a $4M penalty for deleting electronic communications.

Portfolio Pulse from Vandana Singh

June 23, 2023 | 1:16 pm

NGVT

Ingevity Corporation's Capa thermoplastics have been awarded the OK biodegradable SOIL certification by TÜV Austria, confirming their complete biodegradation in soil without environmental harm. This certification opens up new opportunities for Ingevity to enter the multi-billion dollar agricultural and horticultural markets using Capa technology.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 1:03 pm

DUO

FangDD Network Group has received a Nasdaq notice regarding minimum bid price requirements, as its share price has been below $1 for 30 consecutive days.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:48 pm

LIXT

LIXTE Biotechnology Holdings, Inc. (NASDAQ:LIXT) has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share and meets all other criteria for continued listing. The company effected a 1-for-10 reverse stock split to address the issue.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:36 pm

INDT

INDUS Realty Trust (NASDAQ:INDT) has received approval from the Committee on Foreign Investment in the United States (CFIUS) for its merger with IR Parent, LLC and IR Merger Sub II, Inc. All regulatory approvals have been received, and the merger is expected to close on June 29, 2023.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:36 pm

ONDS

Ondas Holdings' subsidiary American Robotics has signed a 6-month agreement with the Massachusetts Department of Transportation Aeronautics Division (MassDOT Aeronautics) to implement its autonomous drone technology, the Optimus System, for improved data collection, safety, and cost reduction in areas such as rail inspections, wetlands assessments, and incident response.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:34 pm

VTGN

Vistagen (NASDAQ:VTGN) has regained full compliance with Nasdaq listing requirements, meeting the minimum $1.00 bid price per share requirement under Nasdaq Listing Rule 5550(a)(2). The company is now in full compliance with all applicable Nasdaq listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:30 pm

LLY

Eli Lilly and Company announced that its drug Jardiance has been recommended for the treatment of adults with chronic kidney disease in the EU. The CHMP of EMA granted a positive opinion, recommending Jardiance for this treatment.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 12:29 pm